Evidence from previous studies show that weight loss can significantly reduce the risk of obesity-related complications and chronic diseases
It also discusses the fact that both oral tablets and injections have been found effective in facilitating weight loss and explores the differences between these medications
In spite of the rising adoption, a recent report revealed 60 percent stopped using their GLP-1 medication before reaching their targeted duration, with many citing negative side effects as a factor for quitting the medication
23 Provider bias, lack of culturally competent care, and limited access to specialists contribute to these disparities
It comes down to pharmacokinetics, individual biology, the specific medication being used, and a handful of factors that most providers never explain in detail
This dual action is not available with phentermine, which has no meaningful effect on blood sugar regulation